Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PSYENCE BIOMEDICAL LTD.

  • Public · NASDAQ: PBM
  • 12 employees
$8.0MMarket cap
12Employees
PBMNASDAQ
2024IPO

About PSYENCE BIOMEDICAL LTD.

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$8.0M
NASDAQ: PBM

15-minute delayed · data by Polygon.io

Market cap
$8.0M
Open
Day range
Prev close
Volume
IPO date
Jan 26, 2024

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review PSYENCE BIOMEDICAL LTD..

Write a review
Explore

Similar companies

Browse all →